rs756255060
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2
The NM_003072.5(SMARCA4):c.4871C>A(p.Pro1624Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003072.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.4967C>A | p.Pro1656Gln | missense_variant | Exon 35 of 36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.4871C>A | p.Pro1624Gln | missense_variant | Exon 34 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.4967C>A | p.Pro1656Gln | missense_variant | Exon 35 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.4871C>A | p.Pro1624Gln | missense_variant | Exon 34 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.4877C>A | p.Pro1626Gln | missense_variant | Exon 34 of 35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.4781C>A | p.Pro1594Gln | missense_variant | Exon 34 of 35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.4781C>A | p.Pro1594Gln | missense_variant | Exon 33 of 34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.4781C>A | p.Pro1594Gln | missense_variant | Exon 33 of 34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.4778C>A | p.Pro1593Gln | missense_variant | Exon 34 of 35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.4292C>A | p.Pro1431Gln | missense_variant | Exon 31 of 32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.3521C>A | p.Pro1174Gln | missense_variant | Exon 27 of 28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.3503C>A | p.Pro1168Gln | missense_variant | Exon 26 of 27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.3365C>A | p.Pro1122Gln | missense_variant | Exon 26 of 27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.3131C>A | p.Pro1044Gln | missense_variant | Exon 24 of 25 | ENSP00000494159.1 | ||||
SMARCA4 | ENST00000538456.4 | c.935C>A | p.Pro312Gln | missense_variant | Exon 7 of 8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
This sequence change replaces proline with glutamine at codon 1656 of the SMARCA4 protein (p.Pro1656Gln). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and glutamine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SMARCA4-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.P1656Q variant (also known as c.4967C>A), located in coding exon 34 of the SMARCA4 gene, results from a C to A substitution at nucleotide position 4967. The proline at codon 1656 is replaced by glutamine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Missense and in-frame variants in SMARCA4 are known to cause neurodevelopmental disorders; however, such associations with rhabdoid tumor predisposition syndrome including small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) are exceedingly rare (Kosho T et al. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75; Jelinic P et al. Nat Genet. 2014 May;46(5):424-6). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at